 |
|
|
|
|
 |
Last Updated: Nov 1, 2009 - 11:48:48 PM |
Latest Research
:
Pharmacology
:
Anti-Clotting Drugs
Direct Intraclot Injection of Alteplase - effective treatment for deep vein thrombosis
A novel treatment for blood clots in the legs appears to be safe and effective, according to a pilot study published in the February issue of Radiology. The study found that injecting or “lacing” the clot with a fiber-binding thrombolytic agent effectively treats deep vein thrombosis (DVT) and reduces the risk of subsequent recurrence or bleeding.
Jan 29, 2008 - 1:25:41 PM
|
Latest Research
:
Pharmacology
:
Anti-Clotting Drugs
Desensitization protocol overcomes allergy to clopidogrel
A careful desensitization protocol can help patients overcome allergic reactions to anti-clotting medication critical to preventing new blockages inside coronary stents, according to a study being presented at the Society for Cardiovascular Angiography and Interventions (SCAI) 29th Annual Scientific Sessions in Chicago, May 1013.
May 12, 2006 - 2:17:37 PM
|
Latest Research
:
Pharmacology
:
Anti-Clotting Drugs
New 'designer' drugs in anti-clotting technology
Volunteers at the Jack and Linda Gill Heart Institute at the University of Kentucky were the first ever to receive a new anti-clotting therapy. The drug and its antidote are being developed for their effectiveness in preventing blood clots while at the same time providing physicians the ability to rapidly reverse the effects of the blood thinner to help safeguard patients against uncontrolled bleeding.
Dec 13, 2005 - 10:04:38 PM
|
Latest Research
:
Pharmacology
:
Anti-Clotting Drugs
FDA Approves Fondaparinux sodium for Prevention of Venous Thromboembolism in Abdominal Surgery
The anti-thrombotic drug ARIXTRA(R) is now indicated for use in patients undergoing abdominal surgery, GlaxoSmithKline (NYSE: GSK) announced today. The U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for ARIXTRA in the prevention of venous thromboembolism (VTE) in patients undergoing abdominal surgery who are at risk of thromboembolic complications.
May 27, 2005 - 6:59:38 PM
|
Latest Research
:
Pharmacology
:
Anti-Clotting Drugs
New Class of Anticlotting Drugs Discovered
Monash University researchers and staff of the Melbourne-based biotechnology company Cerylid Biosciences Ltd, have discovered and developed a new class of anti-clotting drugs that appears to be more effective than aspirin at preventing disease-causing blood clots and has fewer side effects.
Apr 18, 2005 - 9:39:38 PM
|
<< prev
next >>
|
|
|
|
| Health |
Defensin-1 in honey can work as antibiotic
|
A key mechanism links virgin olive oil to protection against breast cancer
|
South Asians more prone to heart attacks than whites
|
More than skin deep, tanning product of sun's rays
|
FDA should adopt risk-based approach to food safety
|
Obesity remains an economic issue, Seattle obesity study finds
|
Food insecurity leads to adverse health consequences in pregnancy
|
IOM report recommends framework to evaluate science behind health claims for foods and drugs
|
Social context may be a better indicator of obesity disparities than race
|
Creating new healthy ingredients by innovative milling techniques and processes for cereal grains
|
| | Healthcare |
Four more encephalitis deaths in Uttar Pradesh
|
Medical college in Kalpana Chawla's name coming up in Karnal
|
Vitamin A Supplementation Programme to Stay
|
Frame policy for kidney transplants, court asks government
|
NRHM completes five years, rural health still in disarray
|
Azad overrules IMA's objections to rural MBBS course
|
Biotech industry hails tax sops in Indian budget
|
Junior doctors in Madhya Pradesh call off strike
|
25000 NRI Doctors Could Return to India from UK
|
AIIMS to guide 40 medical colleges on drug reaction
|
| | Latest Research |
Medical Cannabis beneficial for chronic pain control
|
T-tubule disruption occurs before decline in heart function detectable
|
Microfluidic tool for isolating neutrophils
|
Asking women about reproductive coercion reduced the likelihood that the women would continue to experience such pressures
|
ORNL graphite foam technology licensed to LED North America
|
Southampton to conduct UK's first cochlear implant operation to give sound in both ears
|
National Geographic features University of Miami's work on Bahamas 'blue holes'
|
Experimental treatments for cocaine addiction may prevent relapse
|
Core values unite Americans, despite divisions
|
Vitamin A increases the presence of the HIV virus in breast milk
|
| | Medical News |
6 dead, 1,200 sick as diarrhoea hits Doda in Jammu region
|
Dengue spurs sales in mosquito repellents, launch of new products
|
'Delhi dengue situation as bad as 2006'
|
Two CRPF recruits collapse in training session, die
|
Chandigarh man dies of swine flu
|
Government denies HPV vaccine role in reported deaths
|
India, China account for 45 percent multi-drug resistant TB
|
Government taking steps to retain best doctors: Azad
|
95 swine flu deaths in Karnataka till Aug 25
|
By 2030, India's diabetes population will reach 79 mn
|
| | Special Topics |
'Primodial Soup' theory for origin of life rejected in paper
|
Human species could have killed Neanderthal man
|
History, geography also seem to shape our genome
|
3,000 Kerala medical students to attend inter-college meet
|
Tamil Nadu seeks to control deemed universities
|
Spiders which eat together, stay together and multiply
|
Anna Hazare - the keeper of the earth and human conscience
|
Indian American scientist wins top IMO prize
|
Artificial human sperm could make men redundant: experts
|
Will autopsy on Benazir's body become necessary?
|
|
|
